As of 2025-09-01, the Fair Value of Aptevo Therapeutics Inc (APVO) is -28.95 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.64 USD, the upside of Aptevo Therapeutics Inc is -1,864.99%.
With the market price of 1.64 USD and our fair value calculation, Aptevo Therapeutics Inc (APVO) is not a good investment. Investing in APVO stocks now will result in a potential loss of 1,864.99%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -17.75 | -28.46 | 8.03 | -17.41 | -24.00 | -15.92 |
| YoY growth | 56.12% | -60.32% | 128.21% | -316.91% | -37.84% | -46.15% |
| Market Cap (mil) | 6.81 |
| P/E | |
| Forward P/E |
| EPS | -5.79 |
| Avg earnings growth rate | -46.15% |
| TTM earnings | -24.02 |